+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Belgium Infection Control Market - Forecasts from 2020 to 2025

  • ID: 5020040
  • Report
  • April 2020
  • Region: Belgium
  • 85 Pages
  • Knowledge Sourcing Intelligence LLP

FEATURED COMPANIES

  • 3M
  • B. Braun Melsungen AG
  • Belimed
  • Drägerwerk AG & Co. KGaA
  • STERIS plc
The Belgium infection control market is poised to reach US$228.408 million by 2025. One of the most common reasons of the spread of diseases is the improper compliance in regards to the safety and preventive measures that must be taken such as proper washing of hands, sterilizing instruments, disinfecting the patient’s surroundings with techniques such as sterilizing machines, hand sanitizers, alcohol-based floor, and surrounding cleaners, among others. Thus, it has led to an increase in the demand for such solutions and is providing a boost to the market growth and is going to do so over the forecast period.

Moreover, there are guidelines in place by the Institute Scientifique de Sante Publique, Belgium that lays down rules, indicators and guidelines that must be followed in order to prevent and control the spread of diseases in Belgian hospitals. According to the report and guidelines laid down, HAI, which are also known as Hospital Acquired Infections, pose a serious problem and are attributable to around 37,000 deaths in European countries (according to the ECDC). One of the most major and most common guidelines, which is not practiced, is following proper hand hygiene, and there are 5 conditions and moments during which, it must be given utmost importance. These include, before making contact with the patient, before an aseptic task has to be performed after the healthcare professional or worker has been subjected to or been in close contact with bodily fluids. The other moments include after patient contact and contact with patient surroundings. In addition to this, each hospital and medical services institution is provided with a dedicated budget to solve the problems related to infection prevention and control.

In conjunction, the Belgian Infection control society or (BICS) is a scientific society that is for representing the healthcare workers and individuals that are involved in services and solutions related to infection control and prevention. The main objective of this society is to promote the knowledge and competence in the domain of the techniques of proper and effective detection to be used during the care of the patients.

Furthermore, the interest being shown by the market payers in order to provide the population with innovative and advanced products. For example, STERIS, which is a company based in Ireland and is one of the leaders in providing infection prevention and control solutions offers different products as a part of their portfolio. If offers two different products under its product line of Surgical Instrument Cleaning Chemistries called the “Prolystica Ultra Concentrate Cleaning Chemistries”, which is a product that has been specifically designed for the use on automated washing and disinfectant machines for the surgical instruments and to provide high-performance formulation to deliver a low-foam environment. It also offers a product for manual cleaning is called the “Prolystica 2X Concentrate Cleaning Chemistries” among some other products.

Segmentation

By Product
  • Disinfectant
  • Sterilization
  • Low-Temperature Sterilization
  • Heat Sterilization
  • Contract Sterilization

By End-User Industry
  • Healthcare
  • Food and Beverage
  • Chemical
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • B. Braun Melsungen AG
  • Belimed
  • Drägerwerk AG & Co. KGaA
  • STERIS plc

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Belgium Infection Control Market By Product
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. Belgium Infection Control Market By End-User Industry
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. Competitive Intelligence
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. Companies Mentioned
8.1. 3M
8.2. Drägerwerk AG & Co. KGaA
8.3. Belimed
8.4. B. Braun Melsungen AG
8.5. STERIS plc
8.6. List is not Exhaustive*
Note: Product cover images may vary from those shown
  • 3M
  • Drägerwerk AG & Co. KGaA
  • Belimed
  • B. Braun Melsungen AG
  • STERIS plc
Note: Product cover images may vary from those shown